Search »

FDA to Hold DTC Hearing in November

The FDA will hold a public hearing November 1 and 2 to discuss the issue of direct-to-consumer pharmaceutical advertising, AdAge reports. While the last public hearings on DTC advertising didn’t produce any guidelines to regulate the category, the consensus is that this time, the FDA will “produce something of substance,” according to a chief marketing officer for a major drug maker.

 

The FDA is also expected to question the use of celebrity endorsers for prescription medications.

In August, the major pharmaceutical companies adopted their own code of conduct for DTC advertising, hoping to preempt government intervention. The Pharmaceutical Research and Manufacturers of America will speak at the public hearing in November.